Status:
WITHDRAWN
Bimodal Analgesia as Form of Pain Control Post Long Bone Fracture
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Tibia Fracture
Femur Fracture
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of this prospective randomized study is to evaluate the risks and benefits of using bimodal analgesia, (i.e. Narcotics and NSAIDS) vs Narcotics alone post long bone fracture.
Detailed Description
This will be a prospective, randomized, control trial looking at the benefit of bimodal analgesia in the treatment of long bone fractures. The traditional pain control regimen following fracture fixat...
Eligibility Criteria
Inclusion
- skeletally mature patients over the age of 18 years
- Fracture of Tibia, femur, or Humerus.
Exclusion
- Open fractures grade III
- Open fractures with suspected compartment syndrome
- history of prior fracture in particular limb.
- Concurrent usage of Steroid drugs, and immunosuppressants.
- Prior or current history of GI bleeding.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 24 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00240396
Start Date
October 1 2005
End Date
September 24 2007
Last Update
March 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215